E. Coli Testing Market Size, Share, Trends, Growth, And Forecast 2024-2032

1
Global E. Coli Testing Market Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• IMARC Group is a global management consulting
  firm that helps the worlds most ambitious
  changemakers to create a lasting impact. Across
  the six major continents and 100 countries, we
  work alongside our business partners as one team
  with a common ambition to achieve unparallelled
  results, gain a competitive edge, and transform
  industries. IMARC Group excels in understanding
  its clients business priorities and delivering
  tailored solutions that drive meaningful
  outcomes. Our client base spans over 3,000
  organizations in the private, public, and social
  sectors, ranging from high-growth startups to
  Fortune 500 companies.
• We provide a comprehensive suite of market entry
  and expansion services. Our offerings include
  thorough market assessment, feasibility studies,
  company incorporation assistance, factory setup
  support, regulatory approvals and licensing
  navigation, branding, marketing and sales
  strategies, competitive landscape and
  benchmarking analyses, pricing and cost research,
  and procurement research. These services are
  designed to assist companies in evaluating market
  opportunities, setting up new entities,
  navigating regulatory landscapes, boosting brand
  visibility, analyzing competitors, and optimizing
  procurement strategies.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled E. Coli Testing Market Market Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," The global E. coli testing
  market size reached US 2.1 Billion in 2023.
• Governments and international organizations have
  established stringent regulations and standards
  to ensure the safety of food and water, which are
  significant vectors for E. coli transmission.
  Regulatory bodies like the U.S. Food and Drug
  Administration (FDA), the European Food Safety
  Authority (EFSA), and the World Health
  Organization (WHO) have set mandatory guidelines
  for the permissible levels of E. coli in
  consumable products and water.
• Failure to meet these standards can result in
  severe penalties, product recalls, and damage to
  a company's reputation. Consequently, companies
  operating in food production, water treatment,
  and pharmaceuticals invest heavily in E. coli
  testing to comply with these regulations, thereby
  driving the demand for testing services and
  technologies. The global trade of food and
  beverages also necessitates adherence to these
  standards, further boosting the E. coli testing
  market.
• Looking forward, IMARC Group expects the market
  to reach US 3.9 Billion by 2032, exhibiting a
  growth rate (CAGR) of 6.6 during 2024-2032.
• Request for a PDF sample of this report
• https//www.imarcgroup.com/cement-mixer-market/req
  uestsample

4
Report Description

• Global E. Coli Testing Market Market Trends
• The growth of the E. coli testing market is also
  driven by the increasing globalization of the
  food supply chain, which has heightened the
  complexity of monitoring and ensuring food safety
  across borders. As food products are sourced from
  diverse regions, the risk of contamination and
  the need for standardized testing protocols have
  surged, compelling companies to adopt robust E.
  coli testing practices.
• Furthermore, consumer demand for transparency and
  higher food safety standards has pressured
  companies to enhance testing measures. In
  addition, the rise of foodborne illnesses linked
  to E. coli has fueled research and development in
  more efficient and scalable testing solutions,
  further propelling the market's expansion.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/e-coli-testing-market

5
Report Segmentation

• Breakup by Product
• Consumables
• Instrumentsr
• Breakup by Test Type
• Environmental Test
• Membrane Filtration (MF)
• Multiple Tube Fermentation (MTF)
• Enzyme Substrate Methods
• Clinical Test
• Polymerase Chain Reaction (PCR) Tests
• Enzyme Immunoassays (EIA)
• Others

6
Report Segmentation

• Breakup by End User
• Hospitals and Clinics
• Diagnostic Laboratories
• Others
• Breakup by Region
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia,
  Indonesia, South Korea, Others)
• Europe (Germany, France, United Kingdom, Italy,
  Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

7
Competitive Landscape

• Accugen Laboratories Inc.
• Alere Inc. (Abbott Laboratories)
• BD (Becton Dickinson and Company)
• bioMérieux (INSTITUT MERIEUX)
• Bio-RAD Laboratories Inc.
• Enzo Life Sciences Inc. (Enzo Biochem Inc.)
• Idexx Laboratories Inc.
• Johnson Johnson
• Meridian Bioscience Inc.
• Nanologix Inc.
• Pro-Lab Diagnostics
• Qiagen N.V.
• Thermo Fisher Scientific Inc.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents
1 Preface 2 Scope and Methodology 2.1
Objectives of the Study 2.2 Stakeholders
2.3 Data Sources 2.3.1 Primary
Sources 2.3.2 Secondary Sources
2.4 Market Estimation 2.4.1
Bottom-Up Approach 2.4.2 Top-Down
Approach 2.5 Forecasting Methodology 3
Executive Summary 4 Introduction 4.1
Overview 4.2 Key Industry Trends 5
Global E. Coli Testing Market 5.1 Market
Overview 5.2 Market Performance 5.3
Impact of COVID-19 5.4 Market Forecast 6
Market Breakup by Product 6.1 Consumables
6.1.1 Market Trends 6.1.2 Market
Forecast 6.2 Instruments 6.2.1
Market Trends 6.2.2 Market Forecast 7
Market Breakup by Test Type 7.1
Environmental Test 7.1.1 Market Trends
7.1.2 Major Types
11
Table of Contents
7.1.2.1 Membrane Filtration (MF)
7.1.2.2 Multiple Tube Fermentation (MTF)
7.1.2.3 Enzyme Substrate Methods 7.1.3
Market Forecast 7.2 Clinical Test
7.2.1 Market Trends 7.2.2 Major Types
7.2.2.1 Polymerase Chain Reaction (PCR)
Tests 7.2.2.2 Enzyme Immunoassays
(EIA) 7.2.2.3 Others 7.2.3
Market Forecast 8 Market Breakup by End User
8.1 Hospitals and Clinics 8.1.1
Market Trends 8.1.2 Market Forecast
8.2 Diagnostic Laboratories 8.2.1
Market Trends 8.2.2 Market Forecast
8.3 Others 8.3.1 Market Trends
8.3.2 Market Forecast 9 Market Breakup by
Region 9.1 North America 9.1.1
United States 9.1.1.1 Market Trends
9.1.1.2 Market Forecast 9.1.2
Canada 9.1.2.1 Market Trends
9.1.2.2 Market Forecast 9.2 Asia Pacific
9.2.1 China 9.2.1.1 Market
Trends
12
Table of Contents
9.2.1.2 Market Forecast 9.2.2
Japan 9.2.2.1 Market Trends
9.2.2.2 Market Forecast 9.2.3 India
9.2.3.1 Market Trends 9.2.3.2
Market Forecast 9.2.4 South Korea
9.2.4.1 Market Trends 9.2.4.2
Market Forecast 9.2.5 Australia
9.2.5.1 Market Trends 9.2.5.2 Market
Forecast 9.2.6 Indonesia
9.2.6.1 Market Trends 9.2.6.2 Market
Forecast 9.2.7 Others 9.2.7.1
Market Trends 9.2.7.2 Market Forecast
9.3 Europe 9.3.1 Germany
9.3.1.1 Market Trends 9.3.1.2 Market
Forecast 9.3.2 France 9.3.2.1
Market Trends 9.3.2.2 Market Forecast
9.3.3 United Kingdom 9.3.3.1
Market Trends 9.3.3.2 Market Forecast
9.3.4 Italy 9.3.4.1 Market
Trends
13
Table of Contents
9.3.4.2 Market Forecast 9.3.5
Spain 9.3.5.1 Market Trends
9.3.5.2 Market Forecast 9.3.6 Russia
9.3.6.1 Market Trends 9.3.6.2
Market Forecast 9.3.7 Others
9.3.7.1 Market Trends 9.3.7.2 Market
Forecast 9.4 Latin America 9.4.1
Brazil 9.4.1.1 Market Trends
9.4.1.2 Market Forecast 9.4.2 Mexico
9.4.2.1 Market Trends 9.4.2.2
Market Forecast 9.4.3 Others
9.4.3.1 Market Trends 9.4.3.2 Market
Forecast 9.5 Middle East and Africa
9.5.1 Market Trends 9.5.2 Market Breakup
by Country 9.5.3 Market Forecast 10 SWOT
Analysis 10.1 Overview 10.2
Strengths 10.3 Weaknesses 10.4
Opportunities 10.5 Threats 11 Value Chain
Analysis 12 Porters Five Forces Analysis
14
Table of Contents
12.1 Overview 12.2 Bargaining Power
of Buyers 12.3 Bargaining Power of
Suppliers 12.4 Degree of Competition
12.5 Threat of New Entrants 12.6 Threat
of Substitutes 13 Price Analysis 14 Competitive
Landscape 14.1 Market Structure 14.2
Key Players 14.3 Profiles of Key Players
14.3.1 Accugen Laboratories Inc.
14.3.1.1 Company Overview 14.3.1.2
Product Portfolio 14.3.2 Alere Inc.
(Abbott Laboratories) 14.3.2.1 Company
Overview 14.3.2.2 Product Portfolio
14.3.3 BD (Becton Dickinson and Company)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio 14.3.3.3
Financials 14.3.3.4 SWOT Analysis
14.3.4 bioMérieux (INSTITUT MERIEUX)
14.3.4.1 Company Overview 14.3.4.2
Product Portfolio 14.3.4.3 Financials
14.3.4.4 SWOT Analysis 14.3.5
Bio-RAD Laboratories Inc. 14.3.5.1
Company Overview 14.3.5.2 Product
Portfolio 14.3.5.3 Financials
14.3.5.4 SWOT Analysis
15
Table of Contents
14.3.6 Enzo Life Sciences Inc. (Enzo
Biochem Inc.) 14.3.6.1 Company
Overview 14.3.6.2 Product Portfolio
14.3.7 Idexx Laboratories Inc.
14.3.7.1 Company Overview 14.3.7.2
Product Portfolio 14.3.7.3 Financials
14.3.7.4 SWOT Analysis 14.3.8
Johnson Johnson 14.3.8.1 Company
Overview 14.3.8.2 Product Portfolio
14.3.8.3 Financials 14.3.8.4
SWOT Analysis 14.3.9 Meridian
Bioscience Inc. 14.3.9.1 Company
Overview 14.3.9.2 Product Portfolio
14.3.9.3 Financials 14.3.9.4
SWOT Analysis 14.3.10 Nanologix Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio 14.3.11
Pro-Lab Diagnostics 14.3.11.1 Company
Overview 14.3.11.2 Product Portfolio
14.3.12 Qiagen N.V. 14.3.12.1
Company Overview 14.3.12.2 Product
Portfolio 14.3.12.3 Financials
14.3.12.4 SWOT Analysis 14.3.13
Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview 14.3.13.2
Product Portfolio
16
Table of Contents
14.3.13.3 Financials14.3.13.4 SWOT Analysis For
more information, visit https//www.imarcgroup.co
m/e-coli-testing-market/toc
17
Partial List of Clients
18
Partial List of Clients
19
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

20
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us